<DOC>
	<DOCNO>NCT01586104</DOCNO>
	<brief_summary>This pilot clinical trial study intensity-modulated radiation therapy ( IMRT ) treat young patient lung metastasis . Specialized radiation therapy delivers high dose radiation directly tumor may kill tumor cell cause less damage normal tissue .</brief_summary>
	<brief_title>Intensity-Modulated Radiation Therapy Treating Younger Patients With Lung Metastases</brief_title>
	<detailed_description>OBJECTIVES : I . To demonstrate feasibility deliver cardiac-sparing IMRT multi-institutional set central quality control child young adult metastatic tumor lung . II . To prospectively determine dosimetric advantage whole lung IMRT treatment standard whole lung irradiation compare treatment plan different organ dose-volume histogram lung , heart , thyroid gland , liver etc . patient enrol study . III . To determine short-term efficacy ( lung-metastases free survival ) acute tolerance whole lung IMRT minimum period six month IMRT . OUTLINE : Patients undergo cardiac-sparing whole lung IMRT . After completion study treatment , patient follow 1-5 year .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<mesh_term>Neuroectodermal Tumors</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive</mesh_term>
	<mesh_term>Rhabdomyosarcoma</mesh_term>
	<mesh_term>Wilms Tumor</mesh_term>
	<mesh_term>Rhabdomyosarcoma , Embryonal</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive , Peripheral</mesh_term>
	<criteria>Patients may Wilms tumor , Ewing Sarcoma , Rhabdomyosarcoma metastatic pediatric malignancy ; patient may single multiple pulmonary metastasis time diagnosis time recurrence ; pulmonary metastasis may define one pulmonary nodule &gt; = 1 cm one pulmonary nodule &gt; = 0.5 cm ; biopsy nodule may consider case doubt The Karnofsky performance status must &gt; = 50 patient &gt; 16 year age Lansky performance status must &gt; = 50 patient = &lt; 16 year age Patients must receive prior radiation therapy part thorax Adequate cardiac function define : Shortening fraction &gt; = 27 % echocardiogram , Ejection fraction &gt; = 50 % radionuclide angiogram Female patient childbearing age must negative pregnancy test Female patient lactate must agree stop breastfeed Sexually active patient childbearing potential must agree use effective contraception Patients enrol Children 's Oncology Group protocols treat whole lung IMRT study Patients prior history radiation therapy thorax adjacent region enter protocol Patient Hodgkin 's Lymphoma eligible study Patients mediastinal mass pulmonary mass require additional mediastinal lung irradiation beyond whole lung irradiation ( WLI ) dose state protocol ineligible study Patients may require concurrent sequential irradiation sit beyond chest neck , flank , abdomen liver eligible study</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>29 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>